Frequency and Severity of Thrombocytopenia in Neonatal Sepsis

Launched by ASSIUT UNIVERSITY · Jan 19, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how common and severe a condition called thrombocytopenia is in newborns who have sepsis, which is a serious infection in the blood. The researchers want to understand how often this low platelet count happens and how serious it can be in babies who are diagnosed with sepsis.

To be part of this study, babies need to be less than 28 days old and have a positive blood culture, which means the doctors have found bacteria in their blood. However, some babies won't be eligible. For example, those whose mothers had certain autoimmune diseases during pregnancy or who have a family history of bleeding disorders will not be included. If your newborn is eligible and participates, they will be monitored closely to help researchers gather important information about this condition. The trial is not yet recruiting participants, but it aims to provide valuable insights into the health challenges faced by newborns with sepsis.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • All neonates less than 28 days old, of both genders, and positive blood culture were included.
• Exclusion criteria:
• • Those with a mother's history of ITP, SLE, or other autoimmune disorders on medication during pregnancy (sulfonamides, quinine, quinidine, thiazides, tolbutamide, vancomycin, hydralazine, and heparin) and neonates with a history of bleeding disorders in the family, trisomies, or Turner/Noonan's syndromes were excluded. All neonates less than 28 days old, of both genders were included.